Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiling Jiang

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Scientific Reports|January 13, 2025
Exploring behavioral determinants of residents' ecological conservation in rural tourism developmentXizhou Tian, Yiling Jiang
Advances in Therapy|April 19, 2021
A Clinical and Budgetary Impact Analysis of Introducing Sugammadex for Routine Reversal of Neuromuscular Blockade in a Hypothetical Cohort in the USYiling Jiang, Lori D Bash, Leif Saager
Expert Review of Pharmacoeconomics & Outcomes Research|September 5, 2014
A public health and budget impact analysis of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UKYiling Jiang, Aline Gauthier, Sam Keeping, et al.
BMC Public Health|March 30, 2017
Systematic review of cost-effectiveness analyses for combinations of prevention strategies against human papillomavirus (HPV) infection: a general trendFrédéric Gervais, Kyle Dunton, Yiling Jiang, et al.
Discover Oncology|July 23, 2025
Integrating molecular docking and network pharmacology to reveal the molecular mechanisms of Anemarrhena asphodeloides in the treatment of non-small cell lung cancerXianshun Xie, Yiling Jiang, Sumei Liu, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|September 6, 2014
Cost-effectiveness of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UKYiling Jiang, Aline Gauthier, Sam Keeping, et al.
Plos One|January 21, 2026
Optimizing regional innovation ecosystems through actor-environment coevolution: A dynamic configurational analysis from a CAS perspectiveHanjun Pang, Yiling Jiang, Lei Wu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 12, 2017
A randomized phase III study of combining erlotinib with bevacizumab and panitumumab versus erlotinib alone as second-line therapy for Chinese patients with non-small-cell lung cancerYing Wang, Hui Wang, Yiling Jiang, et al.
Drug Design, Development and Therapy|January 20, 2025
Intraoperative Administration of Esketamine is Associated with Reduced Opioid Consumption After Laparoscopic Gynecological Surgery: A Randomized Controlled TrialChen Huan, Ting Zhang, Yiling Jiang, et al.
Infectious Diseases and Therapy|July 22, 2021
Budget Impact Analysis of Fidaxomicin Versus Vancomycin for the Treatment of Clostridioides difficile Infection in the United StatesYiling Jiang, Eric M Sarpong, Pamela Sears, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Scientific Reports|January 13, 2025
Exploring behavioral determinants of residents' ecological conservation in rural tourism developmentXizhou Tian, Yiling Jiang
Advances in Therapy|April 19, 2021
A Clinical and Budgetary Impact Analysis of Introducing Sugammadex for Routine Reversal of Neuromuscular Blockade in a Hypothetical Cohort in the USYiling Jiang, Lori D Bash, Leif Saager
Expert Review of Pharmacoeconomics & Outcomes Research|September 5, 2014
A public health and budget impact analysis of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UKYiling Jiang, Aline Gauthier, Sam Keeping, et al.
BMC Public Health|March 30, 2017
Systematic review of cost-effectiveness analyses for combinations of prevention strategies against human papillomavirus (HPV) infection: a general trendFrédéric Gervais, Kyle Dunton, Yiling Jiang, et al.
Discover Oncology|July 23, 2025
Integrating molecular docking and network pharmacology to reveal the molecular mechanisms of Anemarrhena asphodeloides in the treatment of non-small cell lung cancerXianshun Xie, Yiling Jiang, Sumei Liu, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|September 6, 2014
Cost-effectiveness of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UKYiling Jiang, Aline Gauthier, Sam Keeping, et al.
Plos One|January 21, 2026
Optimizing regional innovation ecosystems through actor-environment coevolution: A dynamic configurational analysis from a CAS perspectiveHanjun Pang, Yiling Jiang, Lei Wu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 12, 2017
A randomized phase III study of combining erlotinib with bevacizumab and panitumumab versus erlotinib alone as second-line therapy for Chinese patients with non-small-cell lung cancerYing Wang, Hui Wang, Yiling Jiang, et al.
Drug Design, Development and Therapy|January 20, 2025
Intraoperative Administration of Esketamine is Associated with Reduced Opioid Consumption After Laparoscopic Gynecological Surgery: A Randomized Controlled TrialChen Huan, Ting Zhang, Yiling Jiang, et al.
Infectious Diseases and Therapy|July 22, 2021
Budget Impact Analysis of Fidaxomicin Versus Vancomycin for the Treatment of Clostridioides difficile Infection in the United StatesYiling Jiang, Eric M Sarpong, Pamela Sears, et al.
Pageof 7